Verified Clinical Trials ™ will be attending and exhibiting at the World Vaccine Congress (https://www.terrapinn.com/conference/world-vaccine-congress-washington/index.stm) April 1st – April 4th 2024.
Meet with the Verified Clinical Trials team and learn more about detecting and preventing duplicate research subjects and professional research subjects in your vaccine clinical trials.
Visit us at our exhibit booth # 241 to see a demo of the world’s largest global research subject database to detect and prevent duplicate subjects in clinical trials.
Vaccine clinical trials pose unique challenges with regards to duplicate subjects and other protocol violations. Subjects are typically dosed at the time of screening and will be dosed multiple times if they are dual enrollers. Issues with placebo response and safety are a concern in these instances.
Verified Clinical Trials will present data and metrics on their unique solution to prevent dual enrollment in clinical trials and improve data integrity in your vaccine clinical trials. Verified Clinical Trials immediate results across your studies and other sponsors studies, from phase I – phase IV and across multiple therapeutic indications.
What will you learn? Verified Clinical Trials is the largest and most comprehensive research subject database of its kind utilized by so many of the world’s largest pharma companies and vaccine developers in the world. A global solution used in 50 countries worldwide that detects and prevents professional research subjects from entering your clinical trials at the time of screening. Verified Clinical Trials also offers advanced optional biometric fingerprint verifications. There is no other solution like Verified Clinical Trials.
